Wednesday, August 26, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· January 20, 2026

Meta Platforms: From Heavy AI CapEx to 2026 ROI?

View original at finance.yahoo.com
Meta Platforms: From Heavy AI CapEx to 2026 ROI? This article first appeared on GuruFocus. This past year, Meta Platforms (NASDAQ:META) invested heavily in AI infrastructure, shaking Wall Street's near-term confidence…
Opening lines of the source · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • 2026 expenses will likely grow at a significantly faster rate than in 2025, largely due to infrastructure and personnel costs as new data center capacity comes online

    80% confidence
  • 2025 capital expenditures will exceed $70 billion, approximately 70% higher than in 2024

    80% confidence
  • Time spent on Facebook rose 5% in Q3 2025

    80% confidence
  • Reels is running at a roughly $50 billion annualized revenue rate

    80% confidence
  • Average price per ad rose 10% year-over-year in Q3 2025, credited to AI

    80% confidence
  • Instagram video consumption is up more than 30% year-over-year

    80% confidence
  • Lead-gen campaigns using Advantage+ show a 14% lower cost per lead than traditional campaigns

    80% confidence
  • Advantage+ is handling over $60 billion in annual ad spend

    80% confidence
  • Threads usage jumped 10% in Q3 2025

    80% confidence
  • Meta has spent over $40 billion on R&D to date, with a significant portion allocated to AI/ML

    80% confidence
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Leadership Exodus Rattles Investor Confidence Amid Capex Boom
High-profile departures at top AI labs — Brad Lightcap's exit from OpenAI and an unnamed researcher's departure from Alphabet/Google that triggered a share-price drop — are surfacing talent retention as a market risk factor even as hyperscalers pour record capital into AI infrastructure. The reaction shows investors treating key-person risk at frontier AI labs as material to valuation, a new fragility layered onto an otherwise bullish AI-driven capex cycle.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Broadcom Inc.
Both facts report EPS for Broadcom Inc. for the same fiscal period (Q1 2026) observed on the same date (2026-02-01). However, they report conflicting values: 1.5 USD per share vs 2.05 USD per share. This is a 37% difference for the identical metric and time period, not a value change over time.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,978
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,978 facts checked against source5,251 source documents archived
Query this data → isubstrate.com
Meta Platforms: From Heavy AI CapEx to 2026 ROI? — Source | Via News | ViaNews Market